November 5, 2020

Evaluating the Effect of the Opioid Analgesics Risk Evaluation and Mitigation Strategy Education Program on Prescribing Behaviors and Patient Outcomes–Exploring the Path Forward for Assessment – 12/11/2020 – 12/11/2020

On This Page Date: December 11, 2020 Time: 9:00 AM – 5:00 PM ET Overview The purpose of the public workshop is to have scientific discussions […]
November 5, 2020

FDA 101: How to Use the Consumer Complaint System and MedWatch

Image FDA offers a number of ways to report a complaint. Two of the main reporting systems available to consumers are the Consumer Complaint Reporting system […]
November 5, 2020

Jobs in Oncology/Hematology

FDA is recruiting oncologists and hematologists to serve in the dynamic, highly challenging, and innovative atmosphere of oncology drug development and research. Who We Are [embedded […]
November 4, 2020

Plastikon Healthcare Issues Voluntary Nationwide Recall of Milk of Magnesia Oral Suspension 2400 mg/30 mL due to Microbial Contamination

Summary Company Announcement Date: September 06, 2019 FDA Publish Date: September 09, 2019 Product Type: Drugs Reason for Announcement: Recall Reason Description Microbial Contamination Company Name: […]
November 3, 2020

Coronavirus (COVID-19) Update: November 3, 2020

For Immediate Release: November 03, 2020 The U.S. Food and Drug Administration today announced the following actions taken in its ongoing response effort to the COVID-19 […]
November 3, 2020

SBIA Webinar: Overview of the Guidance for Industry: Control of Nitrosamine Impurities in Human Drugs – 10/02/2020 – 10/02/2020

On This Page Date: October 2, 2020 Time: 8:30 AM – 10:00 AM ET [embedded content] View Slides ABOUT THIS WEBINAR On September 2, 2020, FDA […]
November 3, 2020

“Real-Time Review of Drug Applications is Now a Reality” September 20, 2018 Issue

  Download (PDF – 454KB)   Listen to Podcast (MP3) and Transcript Resources: Upcoming Events: The FDA has started using real-time review of drug applications to evaluate clinical data […]
November 3, 2020

La FDA recomienda evitar el uso de medicamentos AINE durante el embarazo y a partir de las 20 semanas en adelante porque pueden reducir el nivel de líquido amniótico

Buscamos en las publicaciones médicas y en el Sistema de Reportes de Efectos Adversos (FAERS) de la FDA por casos de oligohidramnios o de disfunción renal […]
November 3, 2020

LVWellness & Aesthetics – 609821 – 10/15/2020

Product: DrugsMedical Devices Recipient: Recipient Name Justin Hogan LVWellness & Aesthetics 7030 FM 1488, Suite 220Magnolia, TX 77354United States [email protected] Date:   October 15, 2020 RE: […]
google.com, pub-5711488453051849, DIRECT, f08c47fec0942fa0